Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

532

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

March 10, 2023

Study Completion Date

March 10, 2023

Conditions
Adenocarcinoma of the Prostate
Interventions
BIOLOGICAL

sipuleucel-T

Sipuleucel-T is an autologous cell product consisting of antigen presenting cells (APCs) loaded with recombinant fusion protein composed PAP linked to GM-CSF (PA2024), a recombinant fusion protein composed of prostatic acid phosphatase (PAP), linked to granulocyte-macrophage colony-stimulating factor (GM-CSF).

Trial Locations (56)

10029

Mount Sinai Health System, New York

11747

Integrated Medical Professionals, PLLC, Melville

13210

Associated Medical Professionals of NY, PLLC (AMP), Syracuse

17604

Lancaster Urology, Lancaster

19004

Urologic Consultants of Southeastern Pennsylvania, Bala-Cynwyd

20889

Walter Reed National Military Medical Center, Bethesda

21204

Chesapeake Urology, Towson

21224

Johns Hopkins University School of Medicine, Baltimore

23235

Virginia Urology, Richmond

23462

Urology of Virginia, Virginia Beach

27612

Associated Urologists of North Carolina - Raleigh, Raleigh

29572

Carolina Urologic Research Center, Myrtle Beach

30076

Advanced Urology Institute of Georgia, Roswell

32114

Advanced Urology Institute, Daytona Beach

37209

Urology Associates, Nashville

37232

Vanderbilt University, Nashville

38138

The Conrad Pearson Clinic, Germantown

38671

The Urology Group, Southaven

45212

The Urology Group - Norwood Campus, Cincinnati

47130

First Urology, Jeffersonville

48084

Michigan Institute of Urology, PC, Troy

48109

A. Alfred Taubman Health Care Center, Ann Arbor

50266

Iowa Clinical Research Corp., West Des Moines

60010

Comprehensive Urologic Care, Lake Barrington

60026

Gottlieb Memorial Hospital, Glenview

NorthShore University HealthSystem, Glenview

60431

Advanced Urology Associates, Joliet

60612

Cook County Health, Chicago

Rush University, Chicago

60643

Research by Design, Chicago

63110

Washington University School of Medicine, St Louis

66211

Kansas City Urology Care, PA, Overland Park

67226

Wichita Urology Group Research, Wichita

68114

Adult Pediatric Urology and Urogynecology - Omaha, Omaha

68130

Urology Cancer Center and GU Research Network, Omaha

70112

Tulane University, New Orleans

71106

Regional Urology, LLC, Shreveport

72211

Arkansas Urological Associates, PA, Little Rock

73104

University of Oklahoma Health Sciences Center, Oklahoma City

75230

Mary Crowley Cancer Research, Dallas

78229

Urology San Antonio, San Antonio

80045

University of Colorado Hospital Anschutz Cancer Pavilion, Aurora

80211

The Urology Center of Colorado, Denver

80401

Foothills Urology- Golden Office, Golden

85234

Banner MD Anderson Cancer Center, Gilbert

85741

Arizona Institute of Urology, Tucson

Urological Associates of Southern Arizona - East Office, Tucson

90073

VA Greater Los Angeles Healthcare System, Los Angeles

90404

John Wayne Cancer Institute, Santa Monica

90505

Skyline Urology, Torrance

92093

University of California San Diego Moores Cancer Center, La Jolla

92868

University of California Irvine, Orange

97477

Oregon Urology Institute Research, Springfield

98101

Virginia Mason Medical Center, Seattle

08054

Delaware Valley Urology, Mount Laurel

02886

Omega Medical Research, Warwick

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

Dendreon

INDUSTRY